Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
8.40
-0.27 (-3.11%)
At close: Aug 13, 2025, 4:00 PM
8.68
+0.15 (1.76%)
Pre-market: Aug 14, 2025, 8:00 AM EDT
Actuate Therapeutics Market Cap
Actuate Therapeutics has a market cap or net worth of $174.61 million as of August 14, 2025.
Market Cap
174.61M
Enterprise Value
170.72M
1-Year Change
n/a
Ranking
Category
Stock Price
8.40
Market Cap Chart
Since the IPO on August 13, 2024, Actuate Therapeutics's market cap has increased from $152.13M to $174.61M, an increase of 14.78%. That is a compound annual growth rate of 14.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 177.48M | 14.16% |
| Dec 31, 2024 | 155.47M | 2.20% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |